Global Oncology Academy

An Exploration of Current and Emerging Therapies for mCRPC

ReachMD Healthcare Image
RestartResume

    What should we know about the current and emerging therapies for patients with mCRPC? Read more.

    • Overview

      Metastatic castration-resistant prostate cancer (mCRPC) is a severe and advanced stage of prostate cancer that occurs when the disease has spread beyond the prostate gland and is no longer responsive to hormonal therapy. mCRPC is incurable but treatable with a few different treatment options. Find out more about these therapies' mechanisms of action and impact on patient outcomes.

    Facebook Comments

    NEW FEATURES:

    Register

    We’re glad to see you’re enjoying Global Oncology Academy…
    but how about a more personalized experience?

    Register for free